Shobana Balasingam

Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report

Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt et al. · npj Vaccines · 2023 · 100 citations · Full text

Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine

Julia Romanova, Brigitte M. Krenn, Markus Wolschek et al. · PLoS ONE · 2009 · 72 citations · Full text

Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection

Alex Mann, Anthony C. Marriott, Shobana Balasingam et al. · Vaccine · 2006 · 43 citations

Vaccination, Veterinary Vaccine, Cross-protection +8

A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity

Orli Even‐Or, Aviva Joseph, Noga Itskovitz-Cooper et al. · Vaccine · 2011 · 40 citations

Vaccination, Mucosal Vaccination, Cross-protection +10

A Throat Lozenge Containing Amyl Meta Cresol and Dichlorobenzyl Alcohol Has a Direct Virucidal Effect on Respiratory Syncytial Virus, Influenza a and SARS-CoV

John Oxford, Iain Gibb, Shobana Balasingam et al. · Antiviral chemistry & chemotherapy · 2005 · 40 citations · Full text

Respiratory Syncytial Virus, Direct Virucidal Effect, Low Ph +13